AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 16546596 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone administration
Number of subjects: 16
Study 16546596 — intervention group
Group type: COMPARATOR
Intervention: Infrequent tanner control
Number of subjects: 16
Study 14977243 — intervention group
Group type: EXPERIMENTAL
Intervention: Listening to Mozart
Number of subjects: 0
Study 14977243 — intervention group
Group type: COMPARATOR
Intervention: Listening to Beethoven
Number of subjects: 0
Study 11262198 — intervention group
Group type: EXPERIMENTAL
Intervention: canarypox-CMV pp65
Number of subjects: 21
Study 11262198 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 21
Study 9253563 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat and moisture exchanger with electret filters (HMEF)
Number of subjects: 250
Study 9253563 — intervention group
Group type: COMPARATOR
Intervention: No filtering device
Number of subjects: 250
Study 8305334 — intervention group
Group type: COMPARATOR
Intervention: Limited field radiotherapy (LF group)
Number of subjects: 708
Study 8305334 — intervention group
Group type: COMPARATOR
Intervention: Wide field radiotherapy (WF group)
Number of subjects: 708
Study 3505192 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 alpha (OH)D3 + Ca 1.0 g/day
Number of subjects: 61
Study 3505192 — intervention group
Group type: EXPERIMENTAL
Intervention: 1 alpha (OH)D3 1.0 microgram/day
Number of subjects: 61
Study 3505192 — intervention group
Group type: EXPERIMENTAL
Intervention: Ca 1.0 g/day
Number of subjects: 61
Study 3505192 — intervention group
Group type: COMPARATOR
Intervention: Non-treated controls
Number of subjects: 61
Study 30198326 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Bifidobacterium supplementation (1.25×10^10 cfu each of Bifidobacterium longum subsp. longum BB536, B. longum subsp. infantis M‐63, Bifidobacterium breve M‐16V and B. breve B‐3)
Number of subjects: 38
Study 30198326 — intervention group
Group type: EXPERIMENTAL
Intervention: Probiotic Bifidobacterium supplementation
Number of subjects: 38
Study 30198326 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 38
Study 26808580 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychoanalytic-Interactional Therapy (PIT)
Number of subjects: 168
Study 26808580 — intervention group
Group type: EXPERIMENTAL
Intervention: Expert Psychodynamic Therapy (E-PDT)
Number of subjects: 168
Study 26808580 — intervention group
Group type: COMPARATOR
Intervention: Control condition (treatment as usual/waiting for treatment)
Number of subjects: 168
Study 24586994 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg of rosuvastatin
Number of subjects: 71
Study 24586994 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 71
Study 22750188 — intervention group
Group type: EXPERIMENTAL
Intervention: Acceptance and Commitment Therapy (ACT) self‐help volume
Number of subjects: 236
Study 22750188 — intervention group
Group type: COMPARATOR
Intervention: Waitlist (Control)
Number of subjects: 236
Study 20404000 — intervention group
Group type: EXPERIMENTAL
Intervention: Raloxifene (60 mg/d)
Number of subjects: 0
Study 20404000 — intervention group
Group type: COMPARATOR
Intervention: Tamoxifen (20 mg/d)
Number of subjects: 0
Study 17885799 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximum voltage-guided technique (MVGT) for CTI ablation
Number of subjects: 20
Study 17885799 — intervention group
Group type: COMPARATOR
Intervention: Complete anatomical ablation line
Number of subjects: 20
Study 16094549 — intervention group
Group type: EXPERIMENTAL
Intervention: Day hospital treatment
Number of subjects: 95
Study 16094549 — intervention group
Group type: COMPARATOR
Intervention: Inpatient treatment
Number of subjects: 95
Study 16094549 — intervention group
Group type: COMPARATOR
Intervention: Inpatients' relatives
Number of subjects: 95
Study 16094549 — intervention group
Group type: EXPERIMENTAL
Intervention: Day hospital patients' relatives
Number of subjects: 95
Study 12427413 — intervention group
Group type: EXPERIMENTAL
Intervention: Pravastatin 20 mg/day
Number of subjects: 50
Study 12427413 — intervention group
Group type: EXPERIMENTAL
Intervention: Simvastatin 10 mg/day
Number of subjects: 50
Study 12427413 — intervention group
Group type: COMPARATOR
Intervention: Statin-naive control group
Number of subjects: 50
Study 10205101 — intervention group
Group type: EXPERIMENTAL
Intervention: Adrenaline 0.25 ml (1:1000)
Number of subjects: 105
Study 10205101 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 105
Study 7543659 — intervention group
Group type: EXPERIMENTAL
Intervention: Craniectomy
Number of subjects: 37
Study 7543659 — intervention group
Group type: COMPARATOR
Intervention: Conservative treatment
Number of subjects: 37
Study 2198826 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol 0.5 g/kg
Number of subjects: 8
Study 2198826 — intervention group
Group type: EXPERIMENTAL
Intervention: Ethanol 0.8 g/kg
Number of subjects: 8
Study 2198826 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study 328549 — intervention group
Group type: EXPERIMENTAL
Intervention: Pyrithioxine
Number of subjects: 44
Study 30626341 — intervention group
Group type: EXPERIMENTAL
Intervention: Multicomponent exercise program with cognitive training (dual-task training)
Number of subjects: 188
Study 30626341 — intervention group
Group type: COMPARATOR
Intervention: Multicomponent exercise program alone
Number of subjects: 188
Study 27121921 — intervention group
Group type: EXPERIMENTAL
Intervention: iPad presentation of physiotherapy information
Number of subjects: 42
Study 27121921 — intervention group
Group type: COMPARATOR
Intervention: Paper booklet presentation of physiotherapy information
Number of subjects: 42
Study 26349919 — intervention group
Group type: EXPERIMENTAL
Intervention: Sugar-reduced foods and beverages for 8 weeks
Number of subjects: 50
Study 26349919 — intervention group
Group type: COMPARATOR
Intervention: Regular sugar foods and beverages for 8 weeks
Number of subjects: 50
Study 24681586 — intervention group
Group type: EXPERIMENTAL
Intervention: Fast Track intervention
Number of subjects: 0
Study 24681586 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study 22669708 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive intervention and exercises
Number of subjects: 0
Study 22669708 — intervention group
Group type: COMPARATOR
Intervention: Instrumented lumbar fusion
Number of subjects: 0
Study 20643915 — intervention group
Group type: EXPERIMENTAL
Intervention: Tenofovir gel
Number of subjects: 889
Study 20643915 — intervention group
Group type: COMPARATOR
Intervention: Placebo gel
Number of subjects: 889
Study 18356605 — intervention group
Group type: EXPERIMENTAL
Intervention: Cotrimoxazole prophylaxis
Number of subjects: 0
Study 16206598 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of bisoprolol and analapril with trimetazidine (70 mg/day for 6 months)
Number of subjects: 75
Study 16206598 — intervention group
Group type: COMPARATOR
Intervention: Combination of bisoprolol and analapril
Number of subjects: 75
Study 14607719 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic MRI
Number of subjects: 53
Study 14607719 — intervention group
Group type: COMPARATOR
Intervention: Spiral CT
Number of subjects: 53
Study 10432966 — intervention group
Group type: EXPERIMENTAL
Intervention: Fosfo‐soda fleet
Number of subjects: 40
Study 10432966 — intervention group
Group type: COMPARATOR
Intervention: Conventional method (X‐prep)
Number of subjects: 40
Study 8527283 — intervention group
Group type: EXPERIMENTAL
Intervention: TRH 0.5 mg
Number of subjects: 2
Study 8527283 — intervention group
Group type: EXPERIMENTAL
Intervention: TRH 1.0 mg
Number of subjects: 2
Study 8527283 — intervention group
Group type: EXPERIMENTAL
Intervention: RX77368 1 mg
Number of subjects: 2
Study 8527283 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2
Study 1730831 — intervention group
Group type: EXPERIMENTAL
Intervention: Bronchial provocation test with alpha-amylase
Number of subjects: 83
Study 1730831 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal provocation with alpha-amylase
Number of subjects: 83
Study 1730831 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral provocation with alpha-amylase
Number of subjects: 83
Study 1730831 — intervention group
Group type: COMPARATOR
Intervention: Specific IgE values
Number of subjects: 83
Study 6714795 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 micrograms ceruletide
Number of subjects: 16
Study 6714795 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 micrograms ceruletide
Number of subjects: 16
Study 6714795 — intervention group
Group type: EXPERIMENTAL
Intervention: 20 micrograms ceruletide
Number of subjects: 16
Study 6714795 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 31557679 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod 0.5 mg
Number of subjects: 0
Study 31557679 — intervention group
Group type: COMPARATOR
Intervention: Delayed fingolimod (switched from placebo or IFN β‐1a)
Number of subjects: 0
Study 29243805 — intervention group
Group type: EXPERIMENTAL
Intervention: Interactive media
Number of subjects: 310
Study 29243805 — intervention group
Group type: COMPARATOR
Intervention: Silent nature video
Number of subjects: 310
Study 29243805 — intervention group
Group type: COMPARATOR
Intervention: Media-free comparison
Number of subjects: 310
Study 27154462 — intervention group
Group type: EXPERIMENTAL
Intervention: MedSentry remote medication monitoring system
Number of subjects: 25
Study 27154462 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 25
Study 24768553 — intervention group
Group type: EXPERIMENTAL
Intervention: European School Fruit campaign (treated group)
Number of subjects: 0
Study 24768553 — intervention group
Group type: COMPARATOR
Intervention: Control group (supermarkets outside 500 m radius of schools)
Number of subjects: 0
Study 24056905 — intervention group
Group type: EXPERIMENTAL
Intervention: Euglycemic hyperinsulinemia (protocol H)
Number of subjects: 7
Study 24056905 — intervention group
Group type: COMPARATOR
Intervention: Euglycemic normoinsulinemia (protocol N)
Number of subjects: 7
Study 24056905 — intervention group
Group type: EXPERIMENTAL
Intervention: Flicker stimulation
Number of subjects: 7
Study 21419298 — intervention group
Group type: EXPERIMENTAL
Intervention: White ProRoot MTA (WMTA)
Number of subjects: 24
Study 21419298 — intervention group
Group type: EXPERIMENTAL
Intervention: EndoSequence Root Repair Material (ES)
Number of subjects: 24
Study 21419298 — intervention group
Group type: COMPARATOR
Intervention: Calcium hydroxide (POS)
Number of subjects: 24
Study 21419298 — intervention group
Group type: COMPARATOR
Intervention: Saline (NEG)
Number of subjects: 24
Study 19724055 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferasirox (35 mg/kg single dose)
Number of subjects: 15
Study 19724055 — intervention group
Group type: COMPARATOR
Intervention: Control group (adequate response)
Number of subjects: 15
Study 17710426 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotretinoin for the first 10 days of each month for 6 months (group 1)
Number of subjects: 66
Study 17710426 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotretinoin daily for the first month, then first 10 days of each month for 5 months (group 2)
Number of subjects: 66
Study 17710426 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotretinoin daily for 6 months (group 3)
Number of subjects: 66
Study 17710426 — intervention group
Group type: COMPARATOR
Intervention: Comparison between group 1 and group 3
Number of subjects: 66
Study 17710426 — intervention group
Group type: COMPARATOR
Intervention: Groups 1 and 2
Number of subjects: 66
Study 15339234 — intervention group
Group type: EXPERIMENTAL
Intervention: Phonemic perception training
Number of subjects: 34
Study 15339234 — intervention group
Group type: COMPARATOR
Intervention: Control group (listened to computerized books)
Number of subjects: 34
Study 11495074 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg of lansoprazole once daily for 5 days
Number of subjects: 64
Study 11495074 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 64
Study 9778202 — intervention group
Group type: EXPERIMENTAL
Intervention: ACE-I treatment
Number of subjects: 1016
Study 9778202 — intervention group
Group type: COMPARATOR
Intervention: No ACE-I treatment
Number of subjects: 1016
Study 7759929 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic outlet syndrome (TOS) patients
Number of subjects: 20
Study 7759929 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 20
Study 2407872 — intervention group
Group type: EXPERIMENTAL
Intervention: Diltiazem SR monotherapy
Number of subjects: 297
Study 2407872 — intervention group
Group type: EXPERIMENTAL
Intervention: Hydrochlorothiazide monotherapy
Number of subjects: 297
Study 2407872 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy (Diltiazem SR + Hydrochlorothiazide)
Number of subjects: 297
Study 2407872 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 297
Study 7404480 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine heparin
Number of subjects: 43
Study 7404480 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine heparin
Number of subjects: 43
Study 7404480 — intervention group
Group type: COMPARATOR
Intervention: Bovine heparin and Porcine heparin
Number of subjects: 43
Study 7404480 — intervention group
Group type: EXPERIMENTAL
Intervention: Serial blood samples from thrombocytopenic patients
Number of subjects: 43
Study 31810848 — intervention group
Group type: EXPERIMENTAL
Intervention: L-PRF
Number of subjects: 48
Study 31810848 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 48
Study 29649082 — intervention group
Group type: EXPERIMENTAL
Intervention: Active TENS
Number of subjects: 0
Study 29649082 — intervention group
Group type: COMPARATOR
Intervention: Placebo TENS
Number of subjects: 0
Study 29649082 — intervention group
Group type: COMPARATOR
Intervention: No TENS
Number of subjects: 0
Study 28521248 — intervention group
Group type: EXPERIMENTAL
Intervention: Blood transfusion serious game
Number of subjects: 103
Study 28521248 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 103
Study 25405577 — intervention group
Group type: EXPERIMENTAL
Intervention: Chemotherapy (specific regimen not detailed)
Number of subjects: 673
Study 23950921 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time strategy (RTS) game emphasizing maintenance and rapid switching between multiple information and action sources
Number of subjects: 0
Study 23950921 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study 21883648 — intervention group
Group type: EXPERIMENTAL
Intervention: Pure chromated glycerin (CG)
Number of subjects: 102
Study 21883648 — intervention group
Group type: COMPARATOR
Intervention: Chromated glycerin mixed with one‐third lidocaine‐epinephrine 1% (CGX)
Number of subjects: 102
Study 19794979 — intervention group
Group type: EXPERIMENTAL
Intervention: C1 inhibitor
Number of subjects: 100
Study 19794979 — intervention group
Group type: EXPERIMENTAL
Intervention: Conventional risk factors (age, gender, hypertension, BMI)
Number of subjects: 100
Study 17916468 — intervention group
Group type: EXPERIMENTAL
Intervention: RF-based plasma microtenotomy
Number of subjects: 60
Study 17916468 — intervention group
Group type: COMPARATOR
Intervention: Arthroscopic subacromial decompression
Number of subjects: 60
Study 14970894 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation intervention (therapeutic exercises, especially Bobath method) starting on average 15 days after stroke
Number of subjects: 57
Study 14970894 — intervention group
Group type: COMPARATOR
Intervention: Control group (similar pharmacological treatments)
Number of subjects: 57
Study 14970894 — intervention group
Group type: EXPERIMENTAL
Intervention: Rehabilitation intervention
Number of subjects: 57
Study 14970894 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 57
Study 11216977 — intervention group
Group type: EXPERIMENTAL
Intervention: D/P (diltiazem and propranolol)
Number of subjects: 37
Study 11216977 — intervention group
Group type: EXPERIMENTAL
Intervention: F (flecainide)
Number of subjects: 37
Study 11216977 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 11216977 — intervention group
Group type: COMPARATOR
Intervention: Emergency room assistance
Number of subjects: 37
Study 9645278 — intervention group
Group type: EXPERIMENTAL
Intervention: (+)‐tramadol
Number of subjects: 100
Study 9645278 — intervention group
Group type: EXPERIMENTAL
Intervention: (‐)‐tramadol
Number of subjects: 100
Study 9645278 — intervention group
Group type: EXPERIMENTAL
Intervention: Racemate
Number of subjects: 100
Study 9645278 — intervention group
Group type: EXPERIMENTAL
Intervention: Morphine
Number of subjects: 100
Study 9645278 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 7524280 — intervention group
Group type: EXPERIMENTAL
Intervention: Open adenectomy (OA)
Number of subjects: 55
Study 7524280 — intervention group
Group type: COMPARATOR
Intervention: Transurethral resection (TUR)
Number of subjects: 55
Study 2075850 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery scripts with negative affect and explicit smoking urges
Number of subjects: 60
Study 2075850 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery scripts with negative affect alone
Number of subjects: 60
Study 2075850 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery scripts with positive affect alone
Number of subjects: 60
Study 2075850 — intervention group
Group type: EXPERIMENTAL
Intervention: Imagery scripts with neutral affect alone
Number of subjects: 60
Study 378580 — intervention group
Group type: EXPERIMENTAL
Intervention: Dantrolene sodium suspension
Number of subjects: 21
Study 378580 — intervention group
Group type: COMPARATOR
Intervention: Placebo suspension
Number of subjects: 21
Study 31338807 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical stimulation (TES)
Number of subjects: 106
Study 31338807 — intervention group
Group type: COMPARATOR
Intervention: Control (non-stimulus group)
Number of subjects: 106
Study 27808555 — intervention group
Group type: EXPERIMENTAL
Intervention: Baclofen (30 mg/day)
Number of subjects: 122
Study 27808555 — intervention group
Group type: COMPARATOR
Intervention: Benfothiamine (control)
Number of subjects: 122
Study 25475771 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich fibrin (PRF) treatment
Number of subjects: 20
Study 25475771 — intervention group
Group type: COMPARATOR
Intervention: Non-PRF treatment (control)
Number of subjects: 20
Study 23427007 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-fat meal with 50,000 IU vitamin D3
Number of subjects: 62
Study 23427007 — intervention group
Group type: EXPERIMENTAL
Intervention: High-fat meal with 50,000 IU vitamin D3
Number of subjects: 62
Study 23427007 — intervention group
Group type: EXPERIMENTAL
Intervention: No meal with 50,000 IU vitamin D3
Number of subjects: 62
Study 23427007 — intervention group
Group type: COMPARATOR
Intervention: All groups (Low-fat, High-fat, No meal)
Number of subjects: 62
Study 21287288 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa butter (high in stearic acid)
Number of subjects: 10
Study 21287288 — intervention group
Group type: COMPARATOR
Intervention: Olive oil
Number of subjects: 10
Study 20031715 — intervention group
Group type: EXPERIMENTAL
Intervention: Nobori Biolimus A9-eluting stent
Number of subjects: 243
Study 20031715 — intervention group
Group type: COMPARATOR
Intervention: Taxus Liberté paclitaxel-eluting stent
Number of subjects: 243
Study 18032083 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine administered in the morning
Number of subjects: 7
Study 18032083 — intervention group
Group type: COMPARATOR
Intervention: Continuous subcutaneous insulin infusion (CSII) with insulin lispro
Number of subjects: 7
Study 15309229 — intervention group
Group type: EXPERIMENTAL
Intervention: Early phototherapy (started 12 hours after birth, treated for at least 96 hours)
Number of subjects: 81
Study 15309229 — intervention group
Group type: COMPARATOR
Intervention: Late phototherapy (started when transcutaneous bilirubin reached 8 mg/dl, suspended when bilirubin fell to 5 mg/dl)
Number of subjects: 81
Study 11557835 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion (100 mg/d with gradual increase to 200 mg twice daily)
Number of subjects: 50
Study 11557835 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion (continuation phase)
Number of subjects: 50
Study 11557835 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 9631781 — intervention group
Group type: EXPERIMENTAL
Intervention: Early extubation (EE) with reduced dose of fentanyl (15 microg/kg)
Number of subjects: 100
Study 9631781 — intervention group
Group type: COMPARATOR
Intervention: Conventional extubation (CE) with fentanyl (50 microg/kg)
Number of subjects: 100
Study 9631781 — intervention group
Group type: EXPERIMENTAL
Intervention: Early extubation (EE)
Number of subjects: 100
Study 8187295 — intervention group
Group type: EXPERIMENTAL
Intervention: Levothyroxine 0.1 mg daily (Group A)
Number of subjects: 100
Study 8187295 — intervention group
Group type: COMPARATOR
Intervention: No treatment (Group B)
Number of subjects: 100
Study 2886820 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous dihydroergotamine (DHE)
Number of subjects: 12
Study 2886820 — intervention group
Group type: COMPARATOR
Intervention: Intravenous saline (placebo)
Number of subjects: 12
Study 28946534 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance and postural stability exercises in addition to conventional transcutaneous electrical nerve stimulation (TENS), spa and land-based exercises 5 days per week for 3 weeks
Number of subjects: 21
Study 28946534 — intervention group
Group type: COMPARATOR
Intervention: Conventional transcutaneous electrical nerve stimulation (TENS), spa and land-based exercises 5 days per week for 3 weeks
Number of subjects: 21
Study 26632101 — intervention group
Group type: EXPERIMENTAL
Intervention: Azilsartan Medoxomil (AZL-M) 20, 40, and 80 mg QD
Number of subjects: 0
Study 26632101 — intervention group
Group type: EXPERIMENTAL
Intervention: Chlorthalidone (CLD) 12.5 and 25 mg QD
Number of subjects: 0
Study 26632101 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 26695605 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified Blumenthal technique of MSICS
Number of subjects: 50
Study 26695605 — intervention group
Group type: COMPARATOR
Intervention: Phacoemulsification
Number of subjects: 50
Study 23329787 — intervention group
Group type: EXPERIMENTAL
Intervention: Enteral L-arginine supplementation (1.5 mmol/kg/d bid)
Number of subjects: 83
Study 23329787 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 83